SNYDER DAVID S has filed 5 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 140041 shares of Coya Therapeutics, Inc. ($COYA) on January 22, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 22, 2026 | Coya Therapeutics, Inc. | $COYA | SNYDER DAVID S | Chief Financial Officer | A | Stock Option (right to buy) | 140041 | $0.00 | 140,041.0000 | 20,924,456 | 9999.99% | 0.67% |
| Jan. 9, 2025 | Coya Therapeutics, Inc. | $COYA | SNYDER DAVID S | Chief Financial Officer | A | Stock Option (right to buy) | 140562 | $0.00 | 140,562.0000 | 0 | 9999.99% | 0.00% |
| Nov. 14, 2024 | Coya Therapeutics, Inc. | $COYA | SNYDER DAVID S | Chief Financial Officer | P | Common Stock, par value $0.0001 per share | 1800 | $7.19 | 8,800.0000 | 0 | 25.71% | 0.00% |
| June 3, 2024 | Coya Therapeutics, Inc. | $COYA | SNYDER DAVID S | Chief Financial Officer | A | Stock Option (right to buy) | 70596 | $0.00 | 70,596.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Coya Therapeutics, Inc. | $COYA | SNYDER DAVID S | Chief Financial Officer | A | Stock Option (right to buy) | 81819 | $0.00 | 81,819.0000 | 0 | 9999.99% | 0.00% |